Sodium gualenate
CAS No. 6223-35-4
Sodium gualenate ( Guaiazulenesulfonate sodium )
Catalog No. M20600 CAS No. 6223-35-4
Sodium gualenate (Guaiazulenesulfonate sodium) a hydrophilic derivative of guaiazulene (GA) is an unstable compound.?It has anti-inflammatory and wound-healing effects.??
Purity : >98% (HPLC)
Size | Price / USD | Stock | Quantity |
100MG | 51 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSodium gualenate
-
NoteResearch use only not for human use.
-
Brief DescriptionSodium gualenate (Guaiazulenesulfonate sodium) a hydrophilic derivative of guaiazulene (GA) is an unstable compound.?It has anti-inflammatory and wound-healing effects.??
-
DescriptionSodium gualenate (Guaiazulenesulfonate sodium) a hydrophilic derivative of guaiazulene (GA) is an unstable compound.?It has anti-inflammatory and wound-healing effects.??
-
SynonymsGuaiazulenesulfonate sodium
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaOthers
-
Indicationfolic acid antagonists
Chemical Information
-
CAS Number6223-35-4
-
Formula Weight300.35
-
Molecular FormulaC15H17NaO3S
-
Purity>98% (HPLC)
-
SolubilityDMSO:30 mg/mL (99.88 mM)
-
SMILES[Na+].CC(C)c1ccc(C)c2c(cc(C)c2c1)S([O-])(=O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
KCNQ2/3 activator-1
N-[4-(6-Fluoro-3,4-dihydro-2(1H)-isoquinolinyl)-2,6-dimethylphenyl]-3,3-dimethylbutanamide is a chemical compound.
-
5-Hydroxymethyl-2-fu...
5-Hydroxymethyl-2-furancarboxylic acid (Sumiki's acid) is a naturally occurring human metabolite. Sumiki's acid was first identified in the urine of a leukemia patient who was excreting an abnormal amount of its glycine derivative. Sumiki's acid has been found to be a byproduct of the fungus Aspergillus and probably other species of fungi and yeast as well.
-
Zedoarondiol
Zedoarondiol has anti-inflammatory activity, inhibits iNOS, COX-2, and pro-inflammatory cytokine expressions by suppressing the phosphorylations of IKK and MAPKs, and by subsequently inactivating the NF-kappaB pathway.